AbCellera Biologics, Inc. (ABCL)
13.78
+0.04
(+0.29%)
USD |
NASDAQ |
Oct 05, 16:00
13.92
+0.14
(+1.05%)
Pre-Market: 08:22
AbCellera Biologics Total Liabilities (Quarterly) : 233.30M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 233.30M |
| March 31, 2026 | 192.92M |
| December 31, 2025 | 215.59M |
| September 30, 2025 | 222.84M |
| June 30, 2025 | 227.45M |
| March 31, 2025 | 164.03M |
| December 31, 2024 | 154.58M |
| September 30, 2024 | 172.69M |
| June 30, 2024 | 177.33M |
| March 31, 2024 | 222.60M |
| December 31, 2023 | 239.86M |
| September 30, 2023 | 329.42M |
| June 30, 2023 | 342.34M |
| Date | Value |
|---|---|
| March 31, 2023 | 289.42M |
| December 31, 2022 | 307.63M |
| September 30, 2022 | 302.24M |
| June 30, 2022 | 380.93M |
| March 31, 2022 | 384.78M |
| December 31, 2021 | 292.84M |
| September 30, 2021 | 219.34M |
| June 30, 2021 | 184.18M |
| March 31, 2021 | 171.40M |
| December 31, 2020 | 175.03M |
| September 30, 2020 | 53.15M |
| June 30, 2020 | 64.32M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| MindWalk Holdings Corp. | 7.422M |
| Repligen Corp. | 838.15M |
| Bio-Techne Corp. | 570.77M |
| Aurinia Pharmaceuticals, Inc. | 177.40M |
| BioLife Solutions, Inc. | 27.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.308B |
| Shareholders Equity (Quarterly) | 896.02M |
| Debt to Equity Ratio | 0.1514 |
| Current Ratio | 12.77 |
| Net Debt Paydown Yield | -0.56% |